Journal article
Applications of nanotechnology in 3D printed tissue engineering scaffolds
European journal of pharmaceutics and biopharmaceutics, Vol.161, pp.15-28
04/2021
DOI: 10.1016/j.ejpb.2021.01.018
PMCID: PMC7969465
PMID: 33549706
Abstract
[Display omitted]
Tissue engineering is an interdisciplinary field that aims to combine life sciences and engineering to create therapies that regenerate functional tissue. Early work in tissue engineering mostly used materials as inert scaffolding structures, but research has shown that constructing scaffolds from biologically active materials can help with regeneration by enabling cell-scaffold interactions or release of factors that aid in regeneration. Three-dimensional (3D) printing is a promising technique for the fabrication of structurally intricate and compositionally complex tissue engineering scaffolds. Such scaffolds can be functionalized with techniques developed by nanotechnology research to further enhance their ability to stimulate regeneration and interact with cells. Nanotechnological components, nanoscale textures, and microscale/nanoscale printing can all be incorporated into the manufacture of 3D printed scaffolds. This review discusses recent advancements in the merging of nanotechnology with 3D printed tissue engineering scaffolds, with a focus on applications of nanoscale components, nanoscale texture, and innovative printing techniques and the effects observed in vitro and in vivo.
Details
- Title: Subtitle
- Applications of nanotechnology in 3D printed tissue engineering scaffolds
- Creators
- Noah Z Laird - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USATimothy M Acri - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USAJaidev L Chakka - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USAJuliana C Quarterman - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USAWalla I Malkawi - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USASatheesh Elangovan - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USAAliasger K Salem - Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- European journal of pharmaceutics and biopharmaceutics, Vol.161, pp.15-28
- DOI
- 10.1016/j.ejpb.2021.01.018
- PMID
- 33549706
- PMCID
- PMC7969465
- NLM abbreviation
- Eur J Pharm Biopharm
- ISSN
- 0939-6411
- eISSN
- 1873-3441
- Publisher
- Elsevier B.V
- Grant note
- DOI: 10.13039/100000002, name: NIH
- Language
- English
- Date published
- 04/2021
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Pharmaceutical Sciences and Experimental Therapeutics; Craniofacial Anomalies Research Center; Dental Research; Chemical and Biochemical Engineering; Periodontics
- Record Identifier
- 9984216693102771
Metrics
27 Record Views